Prostate Cancer Clinical Trial
— ETADAPTOfficial title:
ETADAPT- Evaluation of the Impact of Patient's Therapeutic Education (PTE) in Adapted Physical Activity (APA) and Dietetic on the Reproducibility of Radiotherapy Sessions for Prostate Cancers.
The primary objective of this study is to evaluate the impact of Patient's Therapeutic Education (PTE) in Adapted Physical Activity (APA) ans dietetic on the reduction of interventions number on rectal volume (laxative or probe). The secondary objectives are to evaluate the contribution of Patient's Therapeutic Education (PTE) between the 2 arms on repositionnind during the radiotherapy session, the gastrointestinal toxicity, the need to use laxative or transit regulating treatment or techniques, the quality of life, the undernutrition and food intake, the evolution in eating/hydratation and physical habits. For the experimetal arm, the satisfaction and the compliance with PTE program will be evaluated, as well as the need of additionnal use of dietary and APA consultations.
Status | Recruiting |
Enrollment | 216 |
Est. completion date | April 2025 |
Est. primary completion date | October 2024 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: I1: Age >= 18 years old. I2: Patient with prostatic adenocarcinoma with indication for first-line or post-operative radiotherapy (adjuvant or biologic recurrence). I3: Patient able to practice a physical activity (certificate of aptitude for adapted physical activity). I4: Life expectancy greater than 6 months. I5: Absence of chronic inflammatory intestinal disease or intestinal surgery. I6: Signed informed consent. I7: Patient covered by a medical insurance. I8. At least 20 sessions of radiotherapy planned Exclusion Criteria: E1: Patient does not understand and cannot read French. E2: Patient followed for a psychiatric pathology or presenting cognitive disorders. E3: Inability to comply with study follow-up goegraphical, social or psychological reasons. E4: Patient requiring tutorship or curatorship or patient deprived of liberty. E5: Participation to another clinical trial which may interfere with principal Endpoint assessment. |
Country | Name | City | State |
---|---|---|---|
France | Groupe Hospitalier Mutualiste de Grenoble Institut Daniel HOLLARD | Grenoble | |
France | Centre Hospitalier Lyon Sud | Pierre-Bénite | |
France | Centre Eugène Marquis | Rennes | |
France | Chu de saint etienne | Saint-Étienne | Rhône-Alpes Auvergne |
France | Institut de Cancérologie de l'Ouest René Gauducheau | Saint-Herblain |
Lead Sponsor | Collaborator |
---|---|
Centre Leon Berard |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluate the impact of Patient's Therapeutic Education in APA on the reduction of interventions number on rectum | Number of uninstallation during the radiotherapy session | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on patient's repositionning efficiency | Rate of patients never uninstalled compared to patients uninstalled during prostate's radiotherapy | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on the gastrointestinal toxicity | Acute gastrointestinal toxicity = grade 2 (NCI- CTCAE V5) | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on the use of laxative or transit regulating treatment or techniques | Prescribed laxatives or transit regulation treatments or techniques | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on patients' quality of life | Using European Organisation for Research and Treatment of Cancer - Core Quality of life questionnaire (QLQC30) (Evaluation of patient's quality of life during the last 7 days - From 4 [worse reply] to 1 [better reply]) | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on the undernutrition | Collection of patients' weight (kg) | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on the food intake | Collection of patients' weight (kg) | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on the undernutrition | Using Socio Economic Factor Index scale (SEFI) (Scale from 10 [I ate my entire meal] to 0 [I did not eat anything]) | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on the food intake | Using Socio Economic Factor Index scale (SEFI) (Scale from 10 [I ate my entire meal] to 0 [I did not eat anything]) | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on the undernutrition | Using the "Eating and hydration habits questionnaire" | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on the food intake | Using the "Eating and hydration habits questionnaire" | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on the evolution in eating habits | Using the "Eating and hydration habits questionnaire" | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on the evolution in hydratation habits | Using the "Eating and hydration habits questionnaire" | An average of 4 months | |
Secondary | Evaluate the contribution of Patient's Therapeutic Education on the evolution in APA habits | Using International Physical Activity Questionnaire (IPAQ) (Description of the physical activity during the last 7 days) | An average of 4 months | |
Secondary | Evaluate patient's satisfaction with Patient's Therapeutic Education program (experimental arm) | Using satisfaction questionnaire (scale from 1 [worse evaluation] to 4 [better evaluation]) | An average of 4 months | |
Secondary | Evaluate the compliance to APA session recommendations | Daily collection of steps numbers | An average of 4 months | |
Secondary | Evaluate the compliance to APA session recommendations | Evaluation during phone calls every 15 days | An average of 4 months | |
Secondary | Evaluate the number of patients requiring additional dietetic session | Evaluation during phone calls every 15 days | An average of 4 months | |
Secondary | Evaluate the number of patients requiring additional APA session | Evaluation during phone calls every 15 days | An average of 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
Active, not recruiting |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |